Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Nov 5, 2014, after the close
10-Q filed Nov 5, 2014, 36 days after period end · 0001104659-14-077051
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $16.92M | $4.93M | $96.41M | $12.22M |
| Net Income | — | -$61.78M | $47.64M | -$20.63M |
| EPS Diluted | -$0.30 |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| -$0.51 |
| $0.42 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.